Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 843

    1.

    A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease.

    Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; the TREAT Investigators.

    N Engl J Med. 2009 Nov 19;361(21):2019-2032. Epub 2009 Oct 30.PMID: 19880844 [PubMed - as supplied by publisher]Related articles

    2.

    Renal Progenitor Cells Contribute to Hyperplastic Lesions of Podocytopathies and Crescentic Glomerulonephritis.

    Smeets B, Angelotti ML, Rizzo P, Dijkman H, Lazzeri E, Mooren F, Ballerini L, Parente E, Sagrinati C, Mazzinghi B, Ronconi E, Becherucci F, Benigni A, Steenbergen E, Lasagni L, Remuzzi G, Wetzels J, Romagnani P.

    J Am Soc Nephrol. 2009 Oct 29. [Epub ahead of print]PMID: 19875807 [PubMed - as supplied by publisher]Related articles

    3.

    Transplantation: time to rethink immunosuppression by mTOR inhibitors?

    Säemann MD, Remuzzi G.

    Nat Rev Nephrol. 2009 Nov;5(11):611-2.PMID: 19855420 [PubMed - in process]Related articles

    4.

    Atypical hemolytic-uremic syndrome.

    Noris M, Remuzzi G.

    N Engl J Med. 2009 Oct 22;361(17):1676-87. Review. No abstract available. PMID: 19846853 [PubMed - indexed for MEDLINE]Related articles

    5.

    Mycophenolate Mofetil Versus Azathioprine in Organ Transplantation.

    Cravedi P, Perna A, Ruggenenti P, Remuzzi G.

    Am J Transplant. 2009 Oct 21. [Epub ahead of print] No abstract available. PMID: 19845579 [PubMed - as supplied by publisher]Related articles

    6.

    Antihypertensive effects of double the maximum dose of valsartan in African-American patients with type 2 diabetes mellitus and albuminuria.

    Weir MR, Hollenberg NK, Zappe DH, Meng X, Parving HH, Viberti G, Remuzzi G.

    J Hypertens. 2009 Oct 3. [Epub ahead of print]PMID: 19809363 [PubMed - as supplied by publisher]Related articles

    7.

    Angiotensin receptors as determinants of life span.

    Cassis P, Conti S, Remuzzi G, Benigni A.

    Pflugers Arch. 2009 Sep 11. [Epub ahead of print]PMID: 19763608 [PubMed - as supplied by publisher]Related articles

    8.

    Toward MSC in solid organ transplantation: 2008 position paper of the MISOT study group.

    Dahlke MH, Hoogduijn M, Eggenhofer E, Popp FC, Renner P, Slowik P, Rosenauer A, Piso P, Geissler EK, Lange C, Chabannes D, Mazzanti B, Bigenzahn S, Bertolino P, Kunter U, Introna M, Rambaldi A, Capelli C, Perico N, Casiraghi F, Noris M, Gotti E, Seifert M, Saccardi R, Verspaget HW, van Hoek B, Bartholomew A, Wekerle T, Volk HD, Remuzzi G, Deans R, Lazarus H, Schlitt HJ, Baan CC; MISOT Study Group.

    Transplantation. 2009 Sep 15;88(5):614-9.PMID: 19741455 [PubMed - indexed for MEDLINE]Related articles

    9.

    The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts.

    Noris M, Cassis P, Azzollini N, Cavinato R, Cugini D, Casiraghi F, Aiello S, Solini S, Cassis L, Mister M, Todeschini M, Abbate M, Benigni A, Trionfini P, Tomasoni S, Mele C, Garlanda C, Polentarutti N, Mantovani A, Remuzzi G.

    J Immunol. 2009 Oct 1;183(7):4249-60. Epub 2009 Sep 4.PMID: 19734209 [PubMed - indexed for MEDLINE]Related articles

    10.

    Impact of The PPAR-{gamma}2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 Diabetes: evidence from Benedict.

    De Cosmo S, Motterlini N, Prudente S, Pellegrini F, Trevisan R, Bossi A, Remuzzi G, Trischitta V, Ruggenenti P; on behalf of the BENEDICT Study Group.

    Diabetes. 2009 Aug 31. [Epub ahead of print]PMID: 19720797 [PubMed - as supplied by publisher]Related articles

    11.

    Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism.

    Vegter S, Perna A, Hiddema W, Ruggenenti P, Remuzzi G, Navis G, Postma MJ.

    Pharmacogenet Genomics. 2009 Sep;19(9):695-703.PMID: 19696696 [PubMed - indexed for MEDLINE]Related articles

    12.

    Adenoviral-mediated gene transfer restores plasma ADAMTS13 antigen and activity in ADAMTS13 knockout mice.

    Trionfini P, Tomasoni S, Galbusera M, Motto D, Longaretti L, Corna D, Remuzzi G, Benigni A.

    Gene Ther. 2009 Nov;16(11):1373-9. Epub 2009 Aug 13.PMID: 19675594 [PubMed - in process]Related articles

    13.

    Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes.

    Gagliardini E, Corna D, Zoja C, Sangalli F, Carrara F, Rossi M, Conti S, Rottoli D, Longaretti L, Remuzzi A, Remuzzi G, Benigni A.

    Am J Physiol Renal Physiol. 2009 Nov;297(5):F1448-56. Epub 2009 Aug 12.PMID: 19675181 [PubMed - indexed for MEDLINE]Related articles

    14.

    Proteinuria: Is the ONTARGET renal substudy actually off target?

    Ruggenenti P, Remuzzi G.

    Nat Rev Nephrol. 2009 Aug;5(8):436-7. No abstract available. PMID: 19639016 [PubMed - indexed for MEDLINE]Related articles

    15.

    V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.

    Perico N, Zoja C, Corna D, Rottoli D, Gaspari F, Haskell L, Remuzzi G.

    Kidney Int. 2009 Nov;76(9):960-7. Epub 2009 Jul 22.PMID: 19625993 [PubMed - in process]Related articles

    16.

    Thrombomodulin mutations in atypical hemolytic-uremic syndrome.

    Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D, Zoja C, Remuzzi G, Conway EM.

    N Engl J Med. 2009 Jul 23;361(4):345-57.PMID: 19625716 [PubMed - indexed for MEDLINE]Related articles

    17.

    Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapy.

    Ruggenenti P, Cattaneo D, Loriga G, Ledda F, Motterlini N, Gherardi G, Orisio S, Remuzzi G.

    Hypertension. 2009 Sep;54(3):567-74. Epub 2009 Jul 20.PMID: 19620516 [PubMed - indexed for MEDLINE]Related articles

    18.

    Treatment of bleeding in dialysis patients.

    Galbusera M, Remuzzi G, Boccardo P.

    Semin Dial. 2009 May-Jun;22(3):279-86. Review.PMID: 19573008 [PubMed - indexed for MEDLINE]Related articles

    19.

    Proteinuria: Increased angiotensin-receptor blocking is not the first option.

    Ruggenenti P, Cravedi P, Remuzzi G.

    Nat Rev Nephrol. 2009 Jul;5(7):367-8.PMID: 19556990 [PubMed - indexed for MEDLINE]Related articles

    20.

    Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats.

    Figliuzzi M, Cornolti R, Perico N, Rota C, Morigi M, Remuzzi G, Remuzzi A, Benigni A.

    Transplant Proc. 2009 Jun;41(5):1797-800.PMID: 19545731 [PubMed - indexed for MEDLINE]Related articles

    21.

    The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristics.

    Lambers Heerspink HJ, Agarwal R, Coyne DW, Parving HH, Ritz E, Remuzzi G, Audhya P, Amdahl MJ, Andress DL, de Zeeuw D.

    Am J Nephrol. 2009;30(3):280-6. Epub 2009 Jun 15.PMID: 19521070 [PubMed - in process]Related articles

    22.

    Treatment of chronic proteinuric kidney disease: what next?

    Benigni A, Remuzzi G.

    Hypertension. 2009 Jul;54(1):29-31. Epub 2009 Jun 8. No abstract available. PMID: 19506097 [PubMed - indexed for MEDLINE]Related articles

    23.

    Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

    Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill J, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R, Uno H; TREAT Investigators.

    Am J Kidney Dis. 2009 Jul;54(1):59-69. Epub 2009 Jun 5.PMID: 19501439 [PubMed - indexed for MEDLINE]Related articles

    24.

    Limited sampling strategies for the estimation of sirolimus daily exposure in kidney transplant recipients on a calcineurin inhibitor-free regimen.

    Cattaneo D, Cortinovis M, Baldelli S, Gotti E, Remuzzi G, Perico N.

    J Clin Pharmacol. 2009 Jul;49(7):773-81. Epub 2009 Jun 2.PMID: 19491334 [PubMed - indexed for MEDLINE]Related articles

    25.

    ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcome.

    Cattaneo D, Ruggenenti P, Baldelli S, Motterlini N, Gotti E, Sandrini S, Salvadori M, Segoloni G, Rigotti P, Donati D, Perico N, Remuzzi G; Mycophenolate Steroids Sparing (MYSS) Genetics Study Group.

    J Am Soc Nephrol. 2009 Jun;20(6):1404-15. Epub 2009 May 21.PMID: 19470683 [PubMed - indexed for MEDLINE]Related articles

    26.

    Low mortality and key aspects of delivery of care for end-stage renal disease in Italy.

    Lauder A, Schieppati A, Conte F, Remuzzi G, Batlle D.

    ScientificWorldJournal. 2009 May 21;9:349-59.PMID: 19468656 [PubMed - indexed for MEDLINE]Related articles

    27.

    Sirolimus to replace calcineurin inhibitors? Too early yet.

    Cravedi P, Ruggenenti P, Remuzzi G.

    Lancet. 2009 Apr 11;373(9671):1235-6. Review. No abstract available. PMID: 19362662 [PubMed - indexed for MEDLINE]Related articles

    28.

    Outcome of renal transplantation from very old donors.

    Rigotti P, Ekser B, Furian L, Baldan N, Valente ML, Boschiero L, Motterlini N, Perna A, Remuzzi G, Ruggenenti P.

    N Engl J Med. 2009 Apr 2;360(14):1464-5. No abstract available. PMID: 19339731 [PubMed - indexed for MEDLINE]Related articles

    29.

    Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

    Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F; AURORA Study Group.

    N Engl J Med. 2009 Apr 2;360(14):1395-407. Epub 2009 Mar 30.PMID: 19332456 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Thrombotic microangiopathy: what not to learn from a meta-analysis.

    Noris M, Remuzzi G.

    Nat Rev Nephrol. 2009 Apr;5(4):186-8. No abstract available. PMID: 19322181 [PubMed - indexed for MEDLINE]Related articles

    31.

    Intensified inhibition of renin-angiotensin system: a way to improve renal protection?

    Cravedi P, Ruggenenti P, Remuzzi G.

    Curr Hypertens Rep. 2009 Apr;11(2):118-24.PMID: 19278601 [PubMed]Related articles

    32.

    The role of chemokines in progressive renal disease.

    Zoja C, Garcia PB, Remuzzi G.

    Front Biosci. 2009 Jan 1;14:1815-22. Review.PMID: 19273165 [PubMed - indexed for MEDLINE]Related articles

    33.

    Developing regulatory-compliant electronic case report forms for clinical trials: experience with the demand trial.

    Ene-Iordache B, Carminati S, Antiga L, Rubis N, Ruggenenti P, Remuzzi G, Remuzzi A.

    J Am Med Inform Assoc. 2009 May-Jun;16(3):404-8. Epub 2009 Mar 4.PMID: 19261946 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Protein load impairs factor H binding promoting complement-dependent dysfunction of proximal tubular cells.

    Buelli S, Abbate M, Morigi M, Moioli D, Zanchi C, Noris M, Zoja C, Pusey CD, Zipfel PF, Remuzzi G.

    Kidney Int. 2009 May;75(10):1050-9. Epub 2009 Feb 25.PMID: 19242507 [PubMed - indexed for MEDLINE]Related articles

    35.

    Thrice-weekly in-center nocturnal hemodialysis: an effective strategy to optimize chronic dialysis therapy.

    Cravedi P, Ruggenenti P, Mingardi G, Sghirlanzoni MC, Remuzzi G.

    Int J Artif Organs. 2009 Jan;32(1):12-9.PMID: 19241359 [PubMed - indexed for MEDLINE]Related articles

    36.

    Screening for chronic kidney disease in emerging countries: feasibility and hurdles.

    Perico N, Bravo RF, De Leon FR, Remuzzi G.

    Nephrol Dial Transplant. 2009 May;24(5):1355-8. Epub 2009 Feb 13. No abstract available. PMID: 19218536 [PubMed - indexed for MEDLINE]Related articles

    37.

    Disruption of the Ang II type 1 receptor promotes longevity in mice.

    Benigni A, Corna D, Zoja C, Sonzogni A, Latini R, Salio M, Conti S, Rottoli D, Longaretti L, Cassis P, Morigi M, Coffman TM, Remuzzi G.

    J Clin Invest. 2009 Mar;119(3):524-30. doi: 10.1172/JCI36703. Epub 2009 Feb 9.PMID: 19197138 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies.

    Bresin E, Gastoldi S, Daina E, Belotti D, Pogliani E, Perseghin P, Scalzulli PR, Paolini R, Marcenò R, Remuzzi G, Galbusera M.

    Thromb Haemost. 2009 Feb;101(2):233-8.PMID: 19190804 [PubMed - indexed for MEDLINE]Related articles

    39.

    Inherited thrombotic thrombocytopenic purpura.

    Galbusera M, Noris M, Remuzzi G.

    Haematologica. 2009 Feb;94(2):166-70. Review. No abstract available. PMID: 19181790 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Medicine and art: one culture?

    Remuzzi G, Simini B.

    Kidney Int. 2009 Feb;75(4):347-8. No abstract available. PMID: 19180146 [PubMed - indexed for MEDLINE]Related articles

    41.

    Humoral immunity in kidney transplantation: what clinicians need to know. Preface.

    Remuzzi G, Chiaramonte S, Perico N, Ronco C.

    Contrib Nephrol. 2009;162:vii-ix. No abstract available. PMID: 19174859 [PubMed - indexed for MEDLINE]Related articles

    42.

    Aldosterone and progression of kidney disease.

    Cortinovis M, Perico N, Cattaneo D, Remuzzi G.

    Ther Adv Cardiovasc Dis. 2009 Apr;3(2):133-43. Epub 2009 Jan 26. Review.PMID: 19171691 [PubMed - indexed for MEDLINE]Related articles

    43.

    Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition.

    Macconi D, Sangalli F, Bonomelli M, Conti S, Condorelli L, Gagliardini E, Remuzzi G, Remuzzi A.

    Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22.PMID: 19164508 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Hepatitis C infection and chronic renal diseases.

    Perico N, Cattaneo D, Bikbov B, Remuzzi G.

    Clin J Am Soc Nephrol. 2009 Jan;4(1):207-20. Epub 2009 Jan 7. Review.PMID: 19129320 [PubMed - indexed for MEDLINE]Related articles

    45.

    Kidney injury molecule 1: in search of biomarkers of chronic tubulointerstitial damage and disease progression.

    Perico N, Cattaneo D, Remuzzi G.

    Am J Kidney Dis. 2009 Jan;53(1):1-4. No abstract available. PMID: 19101395 [PubMed - indexed for MEDLINE]Related articles

    46.

    Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides.

    Macconi D, Chiabrando C, Schiarea S, Aiello S, Cassis L, Gagliardini E, Noris M, Buelli S, Zoja C, Corna D, Mele C, Fanelli R, Remuzzi G, Benigni A.

    J Am Soc Nephrol. 2009 Jan;20(1):123-30. Epub 2008 Dec 17.PMID: 19092126 [PubMed - indexed for MEDLINE]Related articles

    47.

    Liver-kidney transplantation to cure atypical hemolytic uremic syndrome.

    Saland JM, Ruggenenti P, Remuzzi G; Consensus Study Group.

    J Am Soc Nephrol. 2009 May;20(5):940-9. Epub 2008 Dec 17. Review.PMID: 19092117 [PubMed - indexed for MEDLINE]Related articles

    48.

    Rituximab for membranous nephropathy and immune disease: less might be enough.

    Ruggenenti P, Cravedi P, Remuzzi G.

    Nat Clin Pract Nephrol. 2009 Feb;5(2):76-7. Epub 2008 Dec 2. Review. No abstract available. PMID: 19048001 [PubMed - indexed for MEDLINE]Related articles

    49.

    Treating the kidney to cure the heart.

    Cravedi P, Remuzzi G.

    Kidney Int Suppl. 2008 Dec;(111):S2-3. Review.PMID: 19034321 [PubMed - indexed for MEDLINE]Related articles

    50.

    New strategies to prevent cardiovascular risk in chronic kidney disease.

    Luño J, Remuzzi G, Rodriguez-Iturbe B, Ayus JC.

    Kidney Int Suppl. 2008 Dec;(111):S1. No abstract available. PMID: 19034317 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...